Management of Methicillin‐ResistantStaphylococcus aureusBacteremia
Open Access
- 1 June 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 46 (S5) , S386-S393
Abstract
Staphylococcus aureus bacteremia and endocarditis are serious infections that demand prompt clinical attention to ensure good outcomes. of foremost iKeywords
This publication has 58 references indexed in Scilit:
- Pharmacokinetics and Tolerability of Daptomycin at Doses up to 12 Milligrams per Kilogram of Body Weight Once Daily in Healthy VolunteersAntimicrobial Agents and Chemotherapy, 2006
- Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused byStaphylococcus aureusNew England Journal of Medicine, 2006
- Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort studyBMJ, 2006
- Staphylococcus aureus EndocarditisJAMA, 2005
- Telavancin Versus Standard Therapy for Treatment of Complicated Skin and Soft-Tissue Infections Due to Gram-Positive BacteriaClinical Infectious Diseases, 2005
- Staphylococcus aureus bacteremia and endocarditis: the Grady Memorial Hospital experience with methicillin-sensitive S aureus and methicillin-resistant S aureus bacteremiaAmerican Heart Journal, 2004
- Occurrence of MRSA Endocarditis During Linezolid TreatmentEuropean Journal of Clinical Microbiology & Infectious Diseases, 2003
- Comparison of Mortality Associated with Methicillin‐Resistant and Methicillin‐SusceptibleStaphylococcus aureusBacteremia: A Meta‐analysisClinical Infectious Diseases, 2003
- The surgical treatment of infective endocarditisWorld Journal of Surgery, 1989
- Fifteen years' experience with staphylococcus septicemia in a large city hospitalThe American Journal of Medicine, 1957